Recombinant Expression and Purification of C5a
Corresponding Organization :
Other organizations : Aarhus University, Noxxon Pharma (Germany)
Variable analysis
- Recombinant hC5a (mutant Cys704Arg)
- MC5a-desArg
- Not explicitly mentioned
- Expression of proteins as fusions with an N-terminal thioredoxin tag (Trx-A) followed by a hexahistidine tag and a TEV protease cleavage site (Trx-His6-TEV-C5a) in Shuffle T7 Express E. coli cells
- Purification using a two-step Ni-column affinity chromatography, including removal of the affinity-tag by overnight incubation with TEV protease, followed by a cation exchange chromatography on a Source 15S column
- Final protein buffer adjusted to 20 mM HEPES, pH 7.5, 150 mM NaCl before flash freezing and storage at −80 °C
- Expression and purification protocol for mutants of hC5a and mC5a was the same as for native proteins
- Positive control: Human C3a expressed recombinantly following the same protocol as for the C5a proteins
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!